Please login to the form below

Not currently logged in
Email:
Password:

ERS Genomics

This page shows the latest ERS Genomics news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    disease late last year, Bayer announced another gene editing pact this month with ERS Genomics. ... Financial details were not disclosed. Like CRISPR Therapeutics ERS Genomics holds rights to the foundational CRISPR-Cas9 patent portfolio from Dr.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    Succeeds the company’s founder Shaun Foy in the role. ERS Genomics, an Irish biotechnology firm, has appointed Eric Rhodes as its new chief executive officer. ... Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics